R. Balfour Sartor mainly investigates Immunology, Inflammation, Colitis, Ulcerative colitis and Microbiology. R. Balfour Sartor is interested in Immune system, which is a field of Immunology. His studies in Inflammation integrate themes in fields like Fibrosis, Pathology, Small intestine and Intestinal mucosa.
His research in Colitis intersects with topics in Interleukin and Endocrinology. His Ulcerative colitis study combines topics from a wide range of disciplines, such as Gastroenterology, Crohn's disease, Pathogenesis and Arthritis. His studies deal with areas such as Barrier function, Flagellin, Microbial diversity and Immunity as well as Microbiology.
His primary areas of study are Immunology, Microbiology, Colitis, Inflammation and Internal medicine. His Immunology research incorporates themes from Inflammatory bowel disease and Ulcerative colitis. His Microbiology research is multidisciplinary, incorporating elements of Antigen, Enterococcus faecalis, Escherichia coli, Bacteria and Virulence.
Molecular biology, Interleukin 12 and Cell biology is closely connected to Interleukin 10 in his research, which is encompassed under the umbrella topic of Colitis. His Inflammation research is multidisciplinary, relying on both Tumor necrosis factor alpha, Interleukin, Cytokine and Fibrosis, Pathology. R. Balfour Sartor has researched Internal medicine in several fields, including Gastroenterology and Endocrinology.
R. Balfour Sartor spends much of his time researching Colitis, Microbiology, Immunology, Interleukin 10 and Immune system. His biological study spans a wide range of topics, including Inflammation, Feces and Inflammatory bowel disease. His biological study spans a wide range of topics, including Fibrosis and Signal transduction.
His Microbiology study integrates concerns from other disciplines, such as Clostridium, Bacteria, Enterobacter, Host and Enterobacteriaceae. His Pathogenesis study in the realm of Immunology interacts with subjects such as Primary. His work on Interleukin 17 is typically connected to Tropism as part of general Immune system study, connecting several disciplines of science.
The scientist’s investigation covers issues in Immunology, Gut flora, Inflammation, Dysbiosis and Disease. He studies Immunology, focusing on Colitis in particular. His study on Gut flora also encompasses disciplines like
His Inflammation research incorporates themes from Natural killer T cell, CD1D, Aryl hydrocarbon receptor, Intestinal epithelium and Signal transduction. His Dysbiosis research includes elements of Inflammasome, Antibiotics, Adipose tissue, Endocrinology and Transmission. While the research belongs to areas of Disease, R. Balfour Sartor spends his time largely on the problem of Bioinformatics, intersecting his research to questions surrounding Regulation of gene expression, Gene, Genome-wide association study, Gene expression and Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Microbial Influences in Inflammatory Bowel Diseases
R. Balfour Sartor.
Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
Ivaylo Ivanov Ivanov;Rosa de Llanos Frutos;Nicolas Manel;Keiji Yoshinaga.
Cell Host & Microbe (2008)
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
Rodrigo Bibiloni;Richard N Fedorak;Gerald W Tannock;Karen L Madsen.
The American Journal of Gastroenterology (2005)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito;Ali M. Mencin;Geum-Youn Gwak;Geum-Youn Gwak;Jean-Philippe Pradere.
Cancer Cell (2012)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
Weifei Zhu;Jill C. Gregory;Elin Org;Jennifer A. Buffa.
Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases
Daniel N. Frank;Charles E. Robertson;Christina M. Hamm;Zegbeh Kpadeh.
Inflammatory Bowel Diseases (2011)
Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications
Fredrik Bäckhed;Claire M. Fraser;Yehuda Ringel;Mary Ellen Sanders.
Cell Host & Microbe (2012)
The IκB/NF-κB system: a key determinant of mucosal inflammation and protection
Christian Jobin;R. Balfour Sartor.
American Journal of Physiology-cell Physiology (2000)
An update on the use and investigation of probiotics in health and disease
Mary Ellen Sanders;Francisco Guarner;Richard Guerrant;Peter R. Holt.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: